Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 37 (1), 21-28
- https://doi.org/10.1016/0049-3848(85)90029-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASEThe Lancet, 1983
- Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1British Journal of Surgery, 1982
- Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.Circulation, 1981
- A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial diseaseThrombosis Research, 1981
- INTRAVENOUS PROSTACYCLIN FOR ISCHAEMIC ULCERS IN PERIPHERAL ARTERY DISEASEThe Lancet, 1980
- Prostaglandins, Platelets, And AtherosclerosiCritical Reviews in Biochemistry, 1980
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- Simultaneous Measurement of the Calf Blood Flow by Strain-Gauge Plethysmography and the Calf Muscle Blood Flow Measured by133Xenon ClearanceScandinavian Journal of Clinical and Laboratory Investigation, 1968